Geode Capital Management’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,609
| Closed | -$69.9K | – | 4582 |
|
|
2024
Q3 | $69.9K | Buy |
+12,609
| New | +$128K | ﹤0.01% | 4191 |
|
|
2023
Q1 | – | Sell |
-3,397
| Closed | -$25K | – | 4834 |
|
|
2022
Q4 | $25K | Hold |
3,397
| – | – | ﹤0.01% | 4737 |
|
|
2022
Q3 | $23K | Hold |
3,397
| – | – | ﹤0.01% | 4898 |
|
|
2022
Q2 | $24K | Hold |
3,397
| – | – | ﹤0.01% | 4900 |
|
|
2022
Q1 | $39K | Hold |
3,397
| – | – | ﹤0.01% | 4855 |
|
|
2021
Q4 | $109K | Hold |
3,397
| – | – | ﹤0.01% | 4702 |
|
|
2021
Q3 | $215K | Hold |
3,397
| – | – | ﹤0.01% | 4418 |
|
|
2021
Q2 | $298K | Buy |
3,397
+548
| +19% | +$47.6K | ﹤0.01% | 4168 |
|
|
2021
Q1 | $341K | Buy |
2,849
+1,401
| +97% | +$283K | ﹤0.01% | 3943 |
|
|
2020
Q4 | $180K | Buy |
1,448
+427
| +42% | +$29.8K | ﹤0.01% | 3913 |
|
|
2020
Q3 | $61K | Buy |
1,021
+100
| +11% | +$10.4K | ﹤0.01% | 3988 |
|
|
2020
Q2 | $121K | Hold |
921
| – | – | ﹤0.01% | 3808 |
|
|
2020
Q1 | $125K | Buy |
+921
| New | +$97.4K | ﹤0.01% | 3691 |
|
Geode Capital Management's GHSI Position: Q4 2024 in Review
Geode Capital Management sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2024, closing a stake of 12,609 shares — an estimated $69.9K sold.
Geode Capital Management first reported a position in GHSI in Q1 2020 and held it in 13 quarters. The position peaked at $341K in Q1 2021. 0 funds tracked by Wall St. Rank hold GHSI as of Q4 2024.
- Geode Capital Management reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Geode Capital Management sold 12,609 Guardion Health Sciences, Inc. Common Stock shares in Q4 2024, an estimated $69.9K.
- Geode Capital Management first reported a position in Guardion Health Sciences, Inc. Common Stock in Q1 2020 and held it in 13 quarters.
- Geode Capital Management's Guardion Health Sciences, Inc. Common Stock position peaked at $341K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2024.
Based on Geode Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.